About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
16 Jan 2025
This GA4GH Public Attitudes for Genomic Policy forum blog post presents a case study that analysed social media posts on Weibo to understand public perceptions in China about international genetic information sharing. The study’s findings explore how different value systems may impact attitudes towards international data sharing.
By Zhangyu Wang*, Meng Wang*, and Li Du*
(*University of Macau)
Incidents involving the unlawful collection of Chinese biological samples by foreign research teams in the 1990s sparked a public debate in China about unauthorised access to the country’s human genetic resources. In response, the Chinese government tightened its legal control over the cross-border transfer of human genetic resources.[1] Currently, China has implemented stringent legislation concerning personal data protection and genomic data management, which mandates strict requirements for international genomic data sharing. Public sentiments towards these issues could potentially shape China’s future legislative and policy modifications. Nonetheless, there is currently limited knowledge about the public’s perspective on these matters.
Case study conducted to gauge public perspective
In 2023, Nature published “A Pangenome Reference of 36 Chinese Populations” (“the publication”).[2] The published research incorporated the sampling of “116 high-quality de novo assemblies from 58 core samples representing 36 Chinese ethnic groups and 6 assemblies of the Han Chinese majority.”[3] Despite being hailed as a significant achievement by Chinese geneticists, with the potential to substantially contribute to Chinese people’s health benefits,[4] the publication ignited public debate in China about the disclosure and international sharing of Chinese human genomic information for biomedical research purposes.
A case study by Zhangyu Wang, Meng Wang, and Li Du[5] investigated the public debate sparked by the publication in Nature. The authors focused their analysis on how users of Weibo, a popular Chinese social media platform with a considerable user base, responded to the publication. A content analysis was completed to shed light on the public attitudes towards the publication, identify the reasons behind the users’ positive and negative responses, and examine public perceptions on the legal regulation of genetic information sharing and use in China. This case study offers valuable insights into China’s societal attitudes towards international genetic information sharing for biomedical research purposes.
Case study findings
The investigation revealed that prevailing public sentiments towards the publication were negative, with up to 64% of Weibo microblogs showing negative attitudes, while 18% were positive and 18% were neutral. A stark divergence was found between individual users’ accounts and verified government and media accounts. In contrast to consistent praise of the publication in government accounts, 79.6% of microblogs with negative attitudes were posted by private individuals.
Positive responses centred around: 1) the high quality of the publication in Nature; 2) its scientific significance; and 3) its contributions to genetic data sharing and the expansion of scientific knowledge.
The top three negative responses encompassed: 1) the publication as a betrayal of China; 2) low researcher awareness of the need to protect national security and genetic information security; and 3) researchers’ selfishness in pursuing personal interests through the publication.
In summary, in various social media posts, the benefits of sharing human genomic data related to advancements in disease research and scientific progress. In contrast, concerns focused on potential manipulation and misuse of such data by hostile countries. Specifically, fears were expressed that genomic information released through the publication could be used to produce bioweapons or other harmful tools targeted at the Chinese population.
This case study demonstrates the gap between attitudes of Chinese government authorities and the public towards the cross-border transmission of genomic data for research purposes. Other publications suggest that overly strict legal regulations and misinformation during the COVID-19 pandemic likely contributed towards these pervasive negative sentiments among members of the public.[6]
The findings also illustrate the role that a collectivistic culture has played in shaping public perceptions toward international data sharing and highlighting their strong concerns about national security and the overall interests of all Chinese people. The prevailing collectivist mindset has likely reinforced the public’s sense of solidarity and their prioritisation of national security considerations.
The study further shows that members of the public commenting on Weibo tend to misunderstand legal regulations governing genomic data management and cross-border sharing and often have insufficient knowledge of relevant biological sciences. Despite the legal responsibilities established by the Biosecurity Law of China,[7] governmental agencies, official media, and research institutions have not sufficiently educated the public about advances in the biosciences and relevant legal developments.
Recommended next steps
Considering that escalating negative sentiments among the public may increase pressure on scientists and impede long-term policy and legal support for genomic data-related research, the study recommends future investments in public education by governments, researchers, and media. Ultimately, more focused educational outreach would enable more insightful comments and thoughtful recommendations on how to develop a responsible legal framework for international genomic data sharing. The study advocates for prompt official announcements of relevant government approvals on research projects and related genomic data sharing to alleviate potential public fears and misgivings. The construction of an official platform is therefore suggested to strengthen the credibility of official announcements. More guidelines and best practices should also be put in place to assist responsible genomic data sharing and improve communication to the public.
Conclusion
Chinese netizens predominantly oppose international publication of domestic genomic data by local scientists, which emphasise the need to improve public understanding of genetic research, international data sharing, and associated regulations. The discussed case study suggests enhancing policy transparency and security reviews, in addition to establishing an official platform for timely release approvals on research programs and accompanied cross-border data sharing.
References
[1] Chu J. Research and management of human genetic resources in China. Science. 2022;72:5–10 (Original in Chinese); Kang W. The right to genetic information disclosure: commercial exploitation of human genes and benefit-sharing. J Anhui Univ (Philos Soc Sci Ed). 2014;38(2):130–40 (Original in Chinese).
[2] Gao Y, Yang X, Chen H, et al. A pangenome reference of 36 Chinese populations. Nature. 2023;169:112-21. doi: 10.1038/s41586-023-06173-7.
[3] China Science Daily. Completing the Chinese “Puzzle”: Nature publishes a pangenome reference map of Chinese populations (Original in Chinese). 2023. https://news.sciencenet.cn/htmlnews/2023/6/502872.shtm. Accessed 7 Oct 2024.
[4] CCTV NEWS. What are the Chinese “exclusive codes” in the pan-genome map? This “first map” will give you the answer (Original in Chinese). 2023. https://news.cctv.com/2023/06/15/ARTIJJmEUCdr49OMeWgchOVL230615.shtml. Accessed 7 Oct 2024.; Caixin Media. Chinese pan-genome mapping on Nature draws controversy: should genetic data be shared or not? (Original in Chinese). 2023. https://zhishifenzi.blog.caixin.com/archives/268744. Accessed 7 Oct 2024.
[5] Wang Z, Wang M, Du L. Public perceptions of international genetic information sharing for biomedical research in China: a case study of the social media debate on the article “A Pangenome Reference of 36 Chinese Populations” published in Nature. Human Genomics. 2024;18(1): 86. doi: 10.1186/s40246-024-00650-4.
[6] Allington D, Duffy B, Wessely S, Dhavan N, Rubin J. Health-protective behaviour, social media usage and conspiracy belief during the COVID-19 public health emergency. Psychological Medicine. 2021;51(10):1763-9. doi: 10.1017/S0033291721000593; Jia H, Luo X. I wear a mask for my country: conspiracy theories, nationalism, and intention to adopt COVID-19 prevention behaviors at the later stage of pandemic control in China. Health Communication. 2023;38(3):543-51. doi: 10.1080/10410236.2021.1958982.
[7] The Chinese Biosecurity Law mandates government agencies, universities, and news media to publicize and popularize biosecurity laws, regulations, and general knowledge of biosecurity. See: Standing Committee of the National People’s Congress of China. Biosecurity Law of the People’s Republic of China (Original in Chinese). 2021. https://www.gov.cn/xinwen/2020-10/18/content_5552108.htm. Accessed 7 Oct 2024.